Prescription drug · NDA
Lidocaine Hydrochloride and Dextrose NDC 0264-9594
lidocaine hydrochloride anhydrous and dextrose monohydrate · Lidocaine hydrochloride anhydrous .4 g/100mL; Dextrose monohydrate 5 g/100mL · Injection, Solution · Intravenous · B. Braun Medical Inc.
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 0264-9594-10 | 00264959410 | 24 CONTAINER in 1 CASE (0264-9594-10) / 500 mL in 1 CONTAINERMarketed from Apr 8, 1992 | |
| 0264-9594-20 | 00264959420 | 24 CONTAINER in 1 CASE (0264-9594-20) / 250 mL in 1 CONTAINERMarketed from Apr 8, 1992 |
How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Lidocaine Hydrochloride and Dextrose
- Generic name (nonproprietary)
- lidocaine hydrochloride anhydrous and dextrose monohydrate
- Active ingredients
- Lidocaine hydrochloride anhydrous — .4 g/100mLDextrose monohydrate — 5 g/100mL
- Dosage form
- Injection, Solution
- Route
- Intravenous
- Labeler
- B. Braun Medical Inc.
- Product type
- Prescription drug
- Marketing category
- NDA — New Drug ApplicationApplication NDA 019830
- Marketing start
- Listing expires
- Other FDA classes
- Amides (Chemical structure)Local Anesthesia (Physiologic effect)
- Identifiers
- Product ID 0264-9594_9e352802-107c-4f90-babe-4f69c7dc892eSPL ID 9e352802-107c-4f90-babe-4f69c7dc892eSPL set ID 7dff29d9-522d-40eb-a9d9-42377912d640RxCUI 1737723, 1737742, 1737744UNII LX22YL083G, EC2CNF7XFP
- Pharmacologic class
- Amide Local Anesthetic; Antiarrhythmic
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.
- Administration
Drug administration (CPT 96360–96549)
When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.
- NDC on a medical claim
N400264959410followed by a unit qualifier and the quantityPackage 00264-9594-10. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
INDICATIONS AND USAGE Lidocaine hydrochloride administered intravenously is specifically indicated in the acute management of (1) ventricular arrhythmias occurring during cardiac manipulations, such as cardiac surgery and (2) life-threatening arrhythmias which are ventricular in origin, such as occur during acute myocardial infarction.
Excerpt only. Read the full label for complete information.
Other NDCs under NDA 019830
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Lidocaine Hydrochloride and Dextroselidocaine hydrochloride anhydrous and dextrose monohydrate | Lidocaine hydrochloride anhydrous .4 g/100mL; Dextrose monohydrate 5 g/100mL | Injection, SolutionIntravenous | ProPharma Distribution | 84549-594 |
| Lidocaine Hydrochloride and Dextroselidocaine hydrochloride anhydrous and dextrose monohydrate | Lidocaine hydrochloride anhydrous .8 g/100mL; Dextrose monohydrate 5 g/100mL | Injection, SolutionIntravenous | B. Braun Medical Inc. | 0264-9598 |